Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally

被引：6
|
作者：
Behr, Juergen [1 ]
机构：
[1] Univ Hosp LMU, Dept Med 5, German Ctr Lung Res DZL, Munich, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷 / 02期
关键词：
SILDENAFIL; FIBROSIS; ILOPROST;
D O I：
10.1164/rccm.202110-2444ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：144 / 146
页数：4
相关论文
共 50 条
  • [41] Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
    Raina, Amresh
    Coons, James C.
    Kanwar, Manreet
    Murali, Srinivas
    Sokos, George
    Benza, Raymond L.
    [J]. PULMONARY CIRCULATION, 2013, 3 (01) : 116 - 120
  • [42] Inhaled treprostinil sodium (TRE) for the treatment of pulmonary hypertension
    Voswinckel, R
    Enke, B
    Kreckel, A
    Reichenberger, F
    Krick, S
    Gall, H
    Gessler, T
    Schmehl, T
    Kohstall, MG
    Grimminger, F
    Ghofrani, HA
    Seeger, W
    Olschewski, H
    [J]. CIRCULATION, 2004, 110 (17) : 295 - 295
  • [43] Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial
    Nathan, Steven D.
    Tapson, Victor F.
    Elwing, Jean
    Rischard, Franz
    Mehta, Jinesh
    Shapiro, Shelley
    Shen, Eric
    Deng, Chunqin
    Smith, Peter
    Waxman, Aaron
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (02) : 198 - +
  • [44] Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension Due to Parenchymal Lung Disease in the INCREASE Trial
    Nathan, S. D.
    Tapson, V. F.
    Elwing, J. M.
    Rischard, F. P.
    Mehta, J. P.
    Shapiro, S.
    Shen, E.
    Edwards, L.
    Smith, P. M.
    Waxman, A. B.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [45] Real-world use of inhaled treprostinil for lung disease-pulmonary hypertension: A protocol for patient evaluation and prescribing
    Johnson, Shelsey W.
    Finlay, Lauren
    Mathai, Stephen C.
    Goldstein, Ronald H.
    Maron, Bradley A.
    [J]. PULMONARY CIRCULATION, 2022, 12 (03)
  • [46] Pulmonary hypertension in patients with interstitial lung disease
    Karampitsakos, Theodoros
    Tzouvelekis, Argyrios
    Chrysikos, Serafeim
    Bouros, Demosthenes
    Tsangaris, Iraklis
    Fares, Wassim H.
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 50 : 38 - 46
  • [47] Pulmonary hypertension secondary to interstitial lung disease
    Shlobin, Oksana A.
    Nathan, Steven D.
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (02) : 179 - 189
  • [48] THE ANALYSIS OF INTERSTITIAL LUNG DISEASE WITH PULMONARY HYPERTENSION
    Shen, N.
    [J]. RESPIROLOGY, 2011, 16 : 324 - 324
  • [49] Exercise Pulmonary Hypertension in Interstitial Lung Disease
    Henry, K. J.
    Gargani, L.
    Sultan, S.
    Saggar, R.
    Bossone, E.
    Saggar, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [50] Pulmonary hypertension due to interstitial lung disease
    King, Christopher S.
    Nathan, Steven D.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (05) : 459 - 467
12345